NICOX (EPA:COX) | Finanzwire

Basculer en Français

8596	Companies
140106	Keywords
76028	Articles
74806	Press releases

Home
Companies
NICOX

BRIEF

published on 03/19/2025 at 07:35, 15 days ago

Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial

Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE

published on 03/19/2025 at 07:30, 15 days ago

Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025

Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF

published on 01/28/2025 at 07:35, 2 months 6 days ago

Nicox: Participation in Major Congresses in 2025

Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE

published on 01/28/2025 at 07:30, 2 months 6 days ago

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025

Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF

published on 01/22/2025 at 07:35, 2 months 12 days ago

Nicox maintains its eligibility for the PEA-PME

PEA-PME Euronext Investment Ophthalmology Nicox
BRIEF

published on 01/21/2025 at 07:35, 2 months 13 days ago

Nicox: Fourth Quarter 2024 Financial and Business Summary

Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
PRESS RELEASE

published on 01/21/2025 at 07:30, 2 months 13 days ago

Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights
Nicox provides Q4 2024 financial highlights, including €13.7 million revenue and €10.7 million cash. Final patient enrolled in NCX 470 trial, with results expected in Q3 2025

Financial Highlights Nicox Q4 2024 Q3 2025 NCX 470 Trial
BRIEF

published on 12/04/2024 at 07:35, 3 months 30 days ago

Nicox's ZERVIATE Reaches Chinese Market Through Ocumension Partnership

Ophthalmology Nicox ZERVIATE Ocumension China Market
PRESS RELEASE

published on 12/04/2024 at 07:30, 3 months 30 days ago

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream
Nicox announces first commercial sale of ZERVIATE in China by partner Ocumension, creating new revenue stream. ZERVIATE, cetirizine ophthalmic solution, treats allergic conjunctivitis in China market

China Ophthalmology Nicox ZERVIATE Ocumension
BRIEF

published on 11/19/2024 at 07:35, 4 months 14 days ago

Nicox Publishes Adaptive Design Results for NCX 470 Phase 3 Trial

Phase 3 Trial Nicox Glaucoma Treatment Clinical Results NCX 470

Accesswire

Published on 04/03/2025 at 05:10, 3 hours 12 minutes ago

Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 6 hours 47 minutes ago

GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 8 hours 47 minutes ago

Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 12 hours 22 minutes ago

Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 17:25, 14 hours 57 minutes ago

SOBRsafe Announces Reverse Stock Split

View all ACCESSWIRE

EQS Group

Published on 04/03/2025 at 08:15, 7 minutes ago

'CGTN: China-India ties at 75: 'Dragon-Elephant Tango' will benefit both'
Published on 04/03/2025 at 08:00, 21 minutes ago

SWEF: Full Year Results for the Year Ended 31 December 2024
Published on 04/03/2025 at 08:00, 22 minutes ago

Partnership with Claro: cyan AG advances into Latin American market and opens up new growth prospects
Published on 04/03/2025 at 08:00, 22 minutes ago

Transaction in Own Shares
Published on 04/03/2025 at 07:58, 23 minutes ago

Silver47 Exploration: Resource of 169 million ounces silver equivalent is just the beginning

Les Echos

Published on 04/03/2025 at 08:00, 22 minutes ago

Availability of preparatory documents for the Annual Shareholders’ Meeting of OPmobility SE
Published on 04/03/2025 at 00:37, 7 hours 44 minutes ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/02/2025 at 18:05, 14 hours 17 minutes ago

Financial statements - 31 december 2024
Published on 04/02/2025 at 17:45, 14 hours 37 minutes ago

Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 14 hours 37 minutes ago

Availability of the Pre-Q1 2025 Sales Communication

View all LES ECHOS COMFI WIRE